These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 18718186)

  • 1. Another threat to the availability of isotretinoin: ocular side effects have aviation authorities considering restricting use from (even potential) pilots.
    Burkhart CG
    Dermatol Online J; 2008 Jul; 14(7):2. PubMed ID: 18718186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-induced ocular side-effects with isotretinoin.
    Santodomingo-Rubido J; Barrado-Navascués E; Rubido-Crespo MJ
    Ophthalmic Physiol Opt; 2008 Sep; 28(5):497-501. PubMed ID: 18761487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facial edema induced by isotretinoin use: a case and a review of the side effects of isotretinoin.
    Scheinfeld N; Bangalore S
    J Drugs Dermatol; 2006 May; 5(5):467-8. PubMed ID: 16703787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety issues in isotretinoin therapy.
    Hanson N; Leachman S
    Semin Cutan Med Surg; 2001 Sep; 20(3):166-83. PubMed ID: 11594672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Irreversible cataract as a possible side effect of isoretinoin].
    Heuberger A; Büchi ER
    Klin Monbl Augenheilkd; 1994 May; 204(5):465-7. PubMed ID: 8051901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alleged isotretinoin-associated inflammatory bowel disease: disproportionate reporting by attorneys to the Food and Drug Administration Adverse Event Reporting System.
    Stobaugh DJ; Deepak P; Ehrenpreis ED
    J Am Acad Dermatol; 2013 Sep; 69(3):393-8. PubMed ID: 23683730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nudulo-cystic eruption with musculoskeletal pain.
    Grunwald MH; Amichai B
    J Fam Pract; 2007 Mar; 56(3):205-6. PubMed ID: 17343810
    [No Abstract]   [Full Text] [Related]  

  • 8. Isotretinoin prescribing: finding a balance between benefit and risk.
    Stern RS
    Pharmacoepidemiol Drug Saf; 2005 Sep; 14(9):611-3. PubMed ID: 16134100
    [No Abstract]   [Full Text] [Related]  

  • 9. Safety and side effects of the acne drug, oral isotretinoin.
    Charakida A; Mouser PE; Chu AC
    Expert Opin Drug Saf; 2004 Mar; 3(2):119-29. PubMed ID: 15006718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of an infantile acne with oral isotretinoin.
    Sarazin F; Dompmartin A; Nivot S; Letessier D; Leroy D
    Eur J Dermatol; 2004; 14(1):71-2. PubMed ID: 14965803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cost of clear skin: balancing the social and safety costs of iPLEDGE with the efficacy of Accutane (isotretinoin).
    Doshi A
    Seton Hall Law Rev; 2007; 37(2):625-60. PubMed ID: 17294569
    [No Abstract]   [Full Text] [Related]  

  • 12. Ocular side effects associated with isotretinoin.
    Fraunfelder FW
    Drugs Today (Barc); 2004 Jan; 40(1):23-7. PubMed ID: 14988767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible association between isotretinoin and inflammatory bowel disease.
    Reddy D; Siegel CA; Sands BE; Kane S
    Am J Gastroenterol; 2006 Jul; 101(7):1569-73. PubMed ID: 16863562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial Mediterranean fever: attacks during isotretinoin treatment.
    Alli N; Toy GG
    J Am Acad Dermatol; 2002 Dec; 47(6):967. PubMed ID: 12451392
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful acne management in Apert syndrome twins.
    Benjamin LT; Trowers AB; Schachner LA
    Pediatr Dermatol; 2005; 22(6):561-5. PubMed ID: 16354263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conjunctival impression cytology, ocular surface, and tear-film changes in patients treated with systemic isotretinoin.
    Karalezli A; Borazan M; Altinors DD; Dursun R; Kiyici H; Akova YA
    Cornea; 2009 Jan; 28(1):46-50. PubMed ID: 19092405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute acne flare following isotretinoin administration: potential protective role of low starting dose.
    Borghi A; Mantovani L; Minghetti S; Virgili A; Bettoli V
    Dermatology; 2009; 218(2):178-80. PubMed ID: 19060474
    [No Abstract]   [Full Text] [Related]  

  • 18. US FDA Advisory Committee meetings held to discuss isotretinoin, safety issues and a new accutane formulation.
    Maddin S
    Skin Therapy Lett; 2000; 6(2):5. PubMed ID: 11071724
    [No Abstract]   [Full Text] [Related]  

  • 19. Risk tolerance and pilot involvement in hazardous events and flight into adverse weather.
    Pauley K; O'Hare D; Wiggins M
    J Safety Res; 2008; 39(4):403-11. PubMed ID: 18786427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of fixed low-dose isotretinoin (20 mg, alternate days) with topical clindamycin gel in moderately severe acne vulgaris.
    Sardana K; Garg VK; Sehgal VN; Mahajan S; Bhushan P
    J Eur Acad Dermatol Venereol; 2009 May; 23(5):556-60. PubMed ID: 19143903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.